• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第1组代谢型谷氨酸受体拮抗剂与乙醇之间的行为和神经化学相互作用:对其抗成瘾特性的潜在见解。

Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties.

作者信息

Lominac Kevin D, Kapasova Zuzana, Hannun Reem A, Patterson Cole, Middaugh Lawrence D, Szumlinski Karen K

机构信息

Department of Psychology, University of California Santa Barbara, Santa Barbara, CA 93106-9660, USA.

出版信息

Drug Alcohol Depend. 2006 Nov 8;85(2):142-56. doi: 10.1016/j.drugalcdep.2006.04.003. Epub 2006 May 11.

DOI:10.1016/j.drugalcdep.2006.04.003
PMID:16697125
Abstract

Blockade of the mGluR5 subtype of Group 1 metabotropic glutamate receptor (mGluRs) reduces the rewarding effects of ethanol (EtOH), while the effects of mGluR1a blockade remain under-investigated. The present study compared the effects of pretreatment with the mGluR5 antagonist MPEP and the mGluR1a antagonist CPCCPOEt upon behavioral and neurochemical variables associated with EtOH reward in alcohol-preferring C57BL/6J mice. Pretreatment with either antagonist (0-10 mg/kg, IP) dose-dependently reduced measures of EtOH reward in an operant self-administration paradigm and the maximally effective antagonist dose (10 mg/kg) also blocked the expression of EtOH-induced place conditioning, as well as EtOH consumption under 24-h free-access conditions. MPEP pretreatment did not significantly alter the EtOH dose-locomotor response function; however, it prevented EtOH-induced changes in extracellular dopamine, glutamate and GABA in the nucleus accumbens (NAC). In contrast, CPCCOEt shifted the EtOH dose-response function downwards, enhanced the capacity of higher EtOH doses to elevate NAC levels of GABA and lowered extracellular dopamine and glutamate below baseline following EtOH injection. It is suggested that the "anti-alcohol" effects of MPEP may involve an attenuation of the neurochemical signals mediating EtOH reward, whereas those of CPCCOEt may involve an increased sensitivity to the inhibitory effects of EtOH upon brain and behavior.

摘要

阻断第1组代谢型谷氨酸受体(mGluRs)的mGluR5亚型可降低乙醇(EtOH)的奖赏效应,而mGluR1a阻断的效应仍未得到充分研究。本研究比较了用mGluR5拮抗剂MPEP和mGluR1a拮抗剂CPCCOEt预处理对与酒精偏好性C57BL/6J小鼠EtOH奖赏相关的行为和神经化学变量的影响。用任何一种拮抗剂(0 - 10 mg/kg,腹腔注射)预处理均可在操作性自我给药范式中剂量依赖性地降低EtOH奖赏指标,最大有效拮抗剂剂量(10 mg/kg)还可阻断EtOH诱导的位置偏爱表达以及24小时自由摄取条件下的EtOH消耗。MPEP预处理并未显著改变EtOH剂量 - 运动反应函数;然而,它可防止EtOH诱导的伏隔核(NAC)细胞外多巴胺、谷氨酸和GABA的变化。相比之下,CPCCOEt使EtOH剂量反应函数向下移动,增强了较高EtOH剂量升高NAC中GABA水平的能力,并在注射EtOH后使细胞外多巴胺和谷氨酸低于基线水平。提示MPEP的“抗酒精”效应可能涉及介导EtOH奖赏的神经化学信号的减弱,而CPCCOEt的效应可能涉及对EtOH对大脑和行为抑制作用的敏感性增加。

相似文献

1
Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties.第1组代谢型谷氨酸受体拮抗剂与乙醇之间的行为和神经化学相互作用:对其抗成瘾特性的潜在见解。
Drug Alcohol Depend. 2006 Nov 8;85(2):142-56. doi: 10.1016/j.drugalcdep.2006.04.003. Epub 2006 May 11.
2
The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.亲代谢型谷氨酸受体5拮抗剂MPEP可选择性抑制C57BL/6J小鼠乙醇自我给药行为的起始和维持。
Psychopharmacology (Berl). 2006 Jan;183(4):429-38. doi: 10.1007/s00213-005-0217-y. Epub 2005 Nov 15.
3
The mGluR5 antagonist MPEP elevates accumbal dopamine and glycine levels; interaction with strychnine-sensitive glycine receptors.mGluR5 拮抗剂 MPEP 可升高伏隔核多巴胺和甘氨酸水平;与士的宁敏感型甘氨酸受体相互作用。
Addict Biol. 2011 Oct;16(4):591-9. doi: 10.1111/j.1369-1600.2011.00343.x. Epub 2011 Jul 25.
4
The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats.亲代谢型谷氨酸受体5拮抗剂MPEP可降低偏爱酒精(P)大鼠在维持阶段及反复酒精剥夺后操作性乙醇自我给药行为。
Psychopharmacology (Berl). 2005 Apr;179(1):262-70. doi: 10.1007/s00213-005-2175-9. Epub 2005 Feb 17.
5
Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.代谢型谷氨酸受体5(mGluR5)对乙醇镇静、依赖性和消耗量的调节:与阿坎酸作用的关系。
Int J Neuropsychopharmacol. 2008 Sep;11(6):775-93. doi: 10.1017/S1461145708008584. Epub 2008 Apr 1.
6
Pharmacological and anatomical evidence for an interaction between mGluR5- and GABA(A) alpha1-containing receptors in the discriminative stimulus effects of ethanol.在乙醇辨别刺激效应中,代谢型谷氨酸受体5(mGluR5)与含γ-氨基丁酸A受体α1亚基(GABA(A)α1)之间相互作用的药理学和解剖学证据。
Neuropsychopharmacology. 2005 Apr;30(4):747-57. doi: 10.1038/sj.npp.1300616.
7
Metabotropic glutamate receptor 5 activity in the nucleus accumbens is required for the maintenance of ethanol self-administration in a rat genetic model of high alcohol intake.伏隔核中代谢型谷氨酸受体 5 的活性对于维持高酒精摄入大鼠遗传模型中的乙醇自我给药是必需的。
Biol Psychiatry. 2010 May 1;67(9):812-22. doi: 10.1016/j.biopsych.2009.09.016. Epub 2009 Nov 7.
8
The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse.代谢型谷氨酸受体5(mGluR5)拮抗剂2-甲基-6-(苯乙炔基)吡啶(MPEP)可降低可卡因的条件性奖赏效应,但对其他滥用药物无效。
Synapse. 2003 Mar;47(3):240-2. doi: 10.1002/syn.10166.
9
Blockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease.阻断丘脑底核中的代谢型谷氨酸受体(mGluR)可改善帕金森病动物模型中的运动不对称性。
Eur J Neurosci. 2006 Jan;23(1):151-60. doi: 10.1111/j.1460-9568.2005.04550.x.
10
Differential modulation of ethanol-induced sedation and hypnosis by metabotropic glutamate receptor antagonists in C57BL/6J mice.代谢型谷氨酸受体拮抗剂对C57BL/6J小鼠乙醇诱导的镇静和催眠作用的差异调节
Alcohol Clin Exp Res. 2008 Jan;32(1):67-76. doi: 10.1111/j.1530-0277.2007.00554.x. Epub 2007 Dec 7.

引用本文的文献

1
Differential reductions in alcohol consumption and cue-induced alcohol-seeking behavior following mGlu5 receptor inhibition in the prelimbic vs. infralimbic subregions of the rat prefrontal cortex.大鼠前额叶皮质前边缘与下边缘亚区域中代谢型谷氨酸受体5(mGlu5)受体抑制后酒精摄入量及线索诱导的觅酒行为的差异性降低。
Pharmacol Biochem Behav. 2025 Mar;248:173958. doi: 10.1016/j.pbb.2025.173958. Epub 2025 Jan 11.
2
Pharmacology, Signaling and Therapeutic Potential of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators.代谢型谷氨酸受体5负变构调节剂的药理学、信号传导及治疗潜力
ACS Pharmacol Transl Sci. 2024 Nov 5;7(12):3671-3690. doi: 10.1021/acsptsci.4c00213. eCollection 2024 Dec 13.
3
Altered Expression of Neuroplasticity-Related Genes in Alcohol Addiction and Treatment.
酒精成瘾及其治疗中的神经可塑性相关基因表达的改变。
Int J Mol Sci. 2024 Oct 22;25(21):11349. doi: 10.3390/ijms252111349.
4
Sex differences and hormonal regulation of metabotropic glutamate receptor synaptic plasticity.性别差异和激素对代谢型谷氨酸受体突触可塑性的调节。
Int Rev Neurobiol. 2023;168:311-347. doi: 10.1016/bs.irn.2022.10.002. Epub 2022 Nov 11.
5
Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.变构调节代谢型谷氨酸受体作为神经精神疾病治疗的新策略。
Pharmacol Rev. 2022 Jul;74(3):630-661. doi: 10.1124/pharmrev.121.000540.
6
Targeting diacylglycerol lipase reduces alcohol consumption in preclinical models.靶向二酰基甘油脂肪酶可减少临床前模型中的酒精摄入量。
J Clin Invest. 2021 Jul 22;131(17). doi: 10.1172/JCI146861.
7
Functional Analysis of Brain Imaging Suggests Changes in the Availability of mGluR5 and Altered Connectivity in the Cerebral Cortex of Long-Term Abstaining Males with Alcohol Dependence: A Preliminary Study.脑成像的功能分析表明,长期戒酒的酒精依赖男性大脑皮层中代谢型谷氨酸受体5(mGluR5)的可用性发生变化,连接性改变:一项初步研究。
Life (Basel). 2021 May 30;11(6):506. doi: 10.3390/life11060506.
8
Hnrnph1 is a novel regulator of alcohol reward.Hnrnph1 是一种新型的酒精奖赏调节因子。
Drug Alcohol Depend. 2021 Mar 1;220:108518. doi: 10.1016/j.drugalcdep.2021.108518. Epub 2021 Jan 10.
9
Effects of the Positive Allosteric Modulator of Metabotropic Glutamate Receptor 5, VU-29, on Maintenance Association between Environmental Cues and Rewarding Properties of Ethanol in Rats.5-羟色胺受体 5 的正变构调节剂 VU-29 对大鼠环境线索与乙醇奖赏特性之间维持性联系的影响。
Biomolecules. 2020 May 20;10(5):793. doi: 10.3390/biom10050793.
10
Allosteric modulation of metabotropic glutamate receptors in alcohol use disorder: Insights from preclinical investigations.代谢型谷氨酸受体在酒精使用障碍中的变构调节:临床前研究的见解
Adv Pharmacol. 2020;88:193-232. doi: 10.1016/bs.apha.2020.02.002. Epub 2020 Mar 2.